SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-031713
Filing Date
2019-08-13
Accepted
2019-08-13 13:41:14
Documents
10
Period of Report
2019-08-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K insy-8k_20190809.htm 8-K 43652
2 EX-99.1 insy-ex991_9.htm EX-99.1 128965
3 GRAPHIC gje5z0y4wzao000001.jpg GRAPHIC 10404
4 GRAPHIC gje5z0y4wzao000002.jpg GRAPHIC 66223
5 GRAPHIC gje5z0y4wzao000006.jpg GRAPHIC 108548
6 GRAPHIC gje5z0y4wzao000005.jpg GRAPHIC 59901
7 GRAPHIC gje5z0y4wzao000008.jpg GRAPHIC 21105
8 GRAPHIC gje5z0y4wzao000007.jpg GRAPHIC 9695
9 GRAPHIC gje5z0y4wzao000003.jpg GRAPHIC 63602
10 GRAPHIC gje5z0y4wzao000004.jpg GRAPHIC 16639
  Complete submission text file 0001564590-19-031713.txt   665366
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35902 | Film No.: 191019660
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1